Find therapies in clinical trials near you – page 90

Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Study Comparing Cyclophosphamide, Azathioprine, and Tacrolimus for Patients with Antisynthetase Syndrome-Related Interstitial Lung Disease

Study Comparing Cyclophosphamide, Azathioprine, and Tacrolimus for Patients with Antisynthetase Syndrome-Related Interstitial Lung Disease

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Study on the Effects of Paltusotine for Patients with Untreated Acromegaly

Study on the Effects of Paltusotine for Patients with Untreated Acromegaly

Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Study on Masitinib for Patients with Severe Mast Cell Activation Syndrome Unresponsive to Treatment

Study on Masitinib for Patients with Severe Mast Cell Activation Syndrome Unresponsive to Treatment

Study of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors

Study of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Study on Early vs. Late Epoetin Alfa Treatment for Adults with Low-Risk MDS and Anemia Not Requiring Blood Transfusions

Study on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough

Study on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough

Long-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)

Long-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)